Coronary heart disease remains a leading cause of morbidity and mortality. Surrogate
imaging endpoints may allow smaller sample sizes and shorter study durations to expedite …

Atherosclerosis imaging has taken on increasing importance in the understanding of the
natural history of coronary artery disease and the processes leading to luminal narrowing …

New imaging techniques have been used as surrogate markers of atherosclerotic burden to
determine the effects of pharmacologic intervention. The aim of this study was to better …

Many cardiovascular events are clinical manifestations of underlying atherosclerotic
disease. The progression of atherosclerosis, traditionally measured by angiography, is …

Increasing attention has been focused on the appropriate role of surrogate markers in the
development of novel anti‐atherosclerotic therapies. Technological advances in imaging …

Intravascular ultrasound (IVUS) has emerged as a powerful imaging modality for the
assessment of the arterial wall and it's response to the accumulation of atherosclerotic …

New imaging techniques have been used to examine surrogate markers of atherosclerotic
burden to determine the effects of pharmacologic intervention. In this review, we discuss the …

The incremental value of intravascular ultrasound (IVUS), compared with angiographic
analysis of coronary atherosclerosis, originates principally from 2 key features—its …

Clinicians have long used the size of the lumen and the angiogram as a predictor of
coronary events. However, cardiovascular disease is not a disease of the lumen but a …

■ ABSTRACT Intravascular ultrasonography (IVUS) can precisely measure plaque burden
and is being used to test new drug therapies. Other imaging tests may also prove useful to …